首页 | 本学科首页   官方微博 | 高级检索  
检索        


Improved Outcomes of Reimplantation vs Remodeling in Marfan Syndrome: A Propensity-Matched Study
Institution:1. Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, Toronto General Hospital and the University of Toronto, Toronto, Ontario, Canada;1. Department of Cardiovascular Surgery, Robert-Bosch-Hospital, Stuttgart, Germany;2. Department of Cardiac Surgery, Royal Brompton Hospital, London, United Kingdom;3. Department of Anaesthesiology, Robert-Bosch-Hospital, Stuttgart, Germany;1. Division of Cardiothoracic Surgery, Emory University, Atlanta, Georgia;2. Rollins School of Public Health, Emory University, Atlanta, Georgia;1. Division of Cardiac Surgery, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola Hospital, University of Bologna, Italy;2. Division of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S.Orsola Hospital, University of Bologna, Italy;1. Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania;2. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania;3. Duke Clinical Research Institute, Durham, North Carolina;4. Division of Cardiac Surgery, Yale University, New Haven, Connecticut
Abstract:BackgroundValve-sparing root replacement (VSRR) has excellent outcomes when performed in experienced centers in well-selected patients. It is suggested that reimplantation of the aortic valve may have better durability than remodeling in patients with Marfan syndrome (MFS), although long-term comparative data are limited.MethodsBetween 1988 and 2018, 194 patients with MFS underwent VSRR at our institution. From these, we derived a propensity-matched cohort of 68 patients (44 who underwent reimplantation and 24 who had remodeling). Early outcomes included death and perioperative complications. Late outcomes were survival, probability of aortic insufficiency, and reintervention up to 20 years of follow-up. Median follow-up was 17.8 years (interquartile range, 12.0-20.6 years) for the entire matched cohort.ResultsBaseline variables were similar between reimplantation and remodeling patients after matching: age (39 ± 12 vs 40 ± 13 years, P = .75) and male sex (28 64%] vs 15 63%], P = 1.0). Similar 20-year survival was observed after reimplantation compared with remodeling (82% vs 72%, P = .20), whereas the probability of developing greater than mild aortic insufficiency at 20 years was increased after remodeling (5.8% vs 13%, P = .013). More patients underwent reoperation on the aortic valve after a remodeling procedure than after reimplantation of the aortic valve (18% vs 0%, P = .018).ConclusionsVSRR provides excellent long-term survival and freedom from valve-related complications outcomes in patients with MFS. Reimplantation of the aortic valve was associated with a lower risk of aortic valve reoperation and aortic insufficiency than the remodeling procedure after 2 decades of follow-up.
Keywords:AI"}  {"#name":"keyword"  "$":{"id":"kwrd0015"}  "$$":[{"#name":"text"  "_":"aortic insufficiency  BAV"}  {"#name":"keyword"  "$":{"id":"kwrd0025"}  "$$":[{"#name":"text"  "_":"bicuspid aortic valve  CVG"}  {"#name":"keyword"  "$":{"id":"kwrd0035"}  "$$":[{"#name":"text"  "_":"composite valve graft  HTAD"}  {"#name":"keyword"  "$":{"id":"kwrd0045"}  "$$":[{"#name":"text"  "_":"hereditary thoracic aortic disease  IQR"}  {"#name":"keyword"  "$":{"id":"kwrd0055"}  "$$":[{"#name":"text"  "_":"interquartile range  MFS"}  {"#name":"keyword"  "$":{"id":"kwrd0065"}  "$$":[{"#name":"text"  "_":"Marfan syndrome  OR"}  {"#name":"keyword"  "$":{"id":"kwrd0075"}  "$$":[{"#name":"text"  "_":"odds ratio  VSRR"}  {"#name":"keyword"  "$":{"id":"kwrd0085"}  "$$":[{"#name":"text"  "_":"valve-sparing root replacement
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号